STEVEN EDWARDS: Open Payments
NPI 1427246636 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 29 payments from 14 companies in 2025. Trend: 2023 $295 · 2024 $493 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Dexcom, Inc. | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Abbott Laboratories | 2 | $35 |
| Organon LLC | 2 | $35 |
| Astellas Pharma US Inc | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: NURTEC ODT, Kerendia, Auvelity, Dexcom G6 Transmitter, PREVNAR 20, GEMTESA, FREESTYLE LIBRE 3, NEXPLANON.
Industry payments across TX — which companies pay providers there.
